<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15">
 <label>15.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Galani</surname>
    <given-names>IE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Triantafyllia</surname>
    <given-names>V</given-names>
   </name>, 
   <name name-style="western">
    <surname>Eleminiadou</surname>
    <given-names>EE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Koltsida</surname>
    <given-names>O</given-names>
   </name>, 
   <name name-style="western">
    <surname>Stavropoulos</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Manioudaki</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Thanos</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Doyle</surname>
    <given-names>SE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kotenko</surname>
    <given-names>SV</given-names>
   </name>, 
   <name name-style="western">
    <surname>Thanopoulou</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Andreakos</surname>
    <given-names>E</given-names>
   </name>
  </person-group>
  <year>2017</year>
  <article-title>Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness</article-title>. 
  <source>Immunity</source>
  <volume>46</volume>:
  <fpage>875</fpage>â€“
  <lpage>890.e6</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.immuni.2017.04.025</pub-id>.
  <pub-id pub-id-type="pmid">28514692</pub-id>
 </mixed-citation>
</ref>
